01/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

01/2025

Jan 29, 2025, 08:05 | Blog
Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced/Metastatic Breast Cancer
Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a post on X: "Final…
Jan 29, 2025, 08:02 | Blog
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma
Abdul Rahman Jazieh, Chief Executive Officer at Innovative Healthcare Institute, shared a post on Facebook:…
Jan 29, 2025, 07:56 | Blog
Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X: "When control…
Jan 29, 2025, 07:53 | Blog
Krishan Jethwa: Prognostic significance of detectable ctDNA in the NEO-trial
Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, shared a post on X: "Prognostic significance…
Jan 29, 2025, 07:52 | Blog
Kelsey Pan: Encorafenib, cetuximab and nivolumab in patients with BRAF V600E mutated mCRC
Kelsey Pan, Heme/Onc Chief Fellow at MD Anderson Cancer Center, shared a post on X:…
Jan 29, 2025, 07:48 | Blog
How do copy no. deletions in STK11, KEAP1 and SMARCA4 impact outcomes in NSCLC?
Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin, shared a post on X: "How…
Jan 29, 2025, 07:46 | Blog
Krishan Jethwa: Highlighting comparison of OPRA vs AIO-12
Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic shared a post on X: "Highlighting comparison…
Jan 29, 2025, 07:45 | Blog
Eric Singhi: Reducing IRRs with IV amivantamab in EGFR+ mNSCLC post osimertinib/chemotherapy
Eric Singhi, Assistant Professor in the Department of General Oncology at The University of Texas…
Jan 29, 2025, 07:43 | Blog
Pashtoon Kasi: Immunotherapy's Potential in Refractory Patients with Liver Metastases
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared a post…
Jan 29, 2025, 07:41 | Blog
Cathy Eng: Role of ctDNA and the impact on decision making in stage II/III colon cancer disease
Cathy Eng, VICC Associate Director of Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer Center,…
All: 2689 Posts: 271 - 280
Special Coverage